Quantcast

Latest Prostate cancer Stories

genetic testing prostate cancer
2014-09-16 07:06:57

John Hopton for redOrbit.com - Your Universe Online A study of more than 87,000 individuals of European, African, Japanese and Latino ancestry has revealed 23 new genetic susceptibility locations indicating risk of prostate cancer, contributing to greater knowledge and hope for future prevention of the disease. The study, co-led by Keck School of Medicine, University of Southern California (USC), and scientists and researchers in the United Kingdom, is the largest of its kind and the...

2014-09-16 04:21:18

WHIPPANY, N.J., Sept. 16, 2014 /PRNewswire/ -- Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development. The study, called ARAMIS, evaluates ODM-201 in men with castration-resistant prostate cancer who have rising Prostate Specific Antigen (PSA) levels and no detectable metastases. The trial is designed to...

2014-09-15 23:04:47

A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment. Pittsburgh, Pennsylvania (PRWEB) September 15, 2014 A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment. The analysis, published today in the American Journal of Pathology,...

2014-09-15 20:22:10

Data presented at American Society for Radiology (ASTRO) Annual Meeting in San Francisco SAN FRANCISCO, Sept. 15, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced data from two new studies presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting demonstrate the ability of its Decipher® Prostate Cancer Classifier, a genomic test capable of predicting aggressiveness of prostate cancer, to influence treatment decisions and improve patient outcomes for...

2014-09-15 08:29:25

Unusually broad range of tumors treated, other benefits seen in first seven months SAN FRANCISCO, Sept. 15, 2014 /PRNewswire/ -- The nation's first proton therapy center to treat patients exclusively with pencil-beam scanning is reporting exceptional results in delivering cancer treatment since opening for patient care in February. Carl Rossi, M.D., medical director of the Scripps Proton Therapy Center in San Diego, offered the assessment in San Francisco, where the American Society...

2014-09-15 08:29:14

BETHESDA, Md., Sept. 15, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that Linda F. Powers, CEO, will present at SMi's 3rd Annual Cancer Vaccines Conference being held in Central London on September 15-16, 2014. http://photos.prnewswire.com/prnvar/20110329/SF73084LOGO Ms. Powers' presentation will provide updates about the Company's...

2014-09-14 23:00:36

A study led by University of Colorado Cancer Center published today in the journal Nature uses a novel approach to target the activation of a protein that drives some cancers. AURORA, Colo. (PRWEB) September 14, 2014 When active, the protein called Ral can drive tumor growth and metastasis in several human cancers including pancreatic, prostate, lung, colon and bladder. Unfortunately, drugs that block its activity are not available. A study published today in the journal Nature uses a...

2014-09-12 12:25:43

Philips reinforces its leadership in innovation and technology, showcases solutions that increase workflow, consistency and confidence in cancer treatment ANDOVER, Mass., Sept. 12, 2014 /PRNewswire/ -- Royal Philips (NYSE: PHG AEX: PHIA) today announced a number of innovations at ASTRO's 56th Annual Meeting in San Francisco, showcasing solutions that increase workflow automation, confidence, consistency and accuracy in cancer treatment. Producing quality results in less time and enhancing...

2014-09-12 12:24:57

OWINGS MILLS, Md., Sept. 12, 2014 /PRNewswire-USNewswire/ -- September not only marks the end of summer and the start of football season, but is also National Prostate Cancer Awareness Month. This month serves as a reminder to be aware of the most common cancer in American men and the second leading cause of cancer death in men next to skin cancer - prostate cancer. Chesapeake Urology Associates reminds all men to take charge of their health....

2014-09-12 08:23:43

Results Suggest that Oncotype DX® Colon Cancer Test May Reduce Medical Costs Associated with Stage II Disease While Increasing Patient Well-being REDWOOD CITY, Calif., Sept. 12, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that PharmacoEconomics published positive results from a health economic analysis suggesting that use of the Oncotype® DX colon cancer test may result in a significant reduction in direct medical costs and improve patient quality of...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related